Cargando…
Potential Application of Copper Aspirinate in Preventing and Treating Thromboembolic Diseases
The efficacy of copper aspirinate against thrombotic diseases has been tested in animal models. The results show that copper aspirinate, following ig pretreatment for 7 days at 0.012mmol/kg markedly prolonged the bleeding time and inhibited the mortality induced by arachidonic acid (AA) in mice. On...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
1998
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365110/ https://www.ncbi.nlm.nih.gov/pubmed/18475833 http://dx.doi.org/10.1155/MBD.1998.123 |